University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

Not yet recruiting

Conditions: Extubation

First Posted Date: 2024-06-05

Last Posted Date: 2024-11-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 3000

Registration Number: NCT06442930

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

The Semaglutide Study

Recruiting

Conditions: Fasting

First Posted Date: 2024-05-20

Last Posted Date: 2024-05-20

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT06420739

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

Phase 2

Recruiting

Conditions: Advanced Cancer
Stage IV Melanoma
Endocrine Cancer
Stage IV Solid Tumor Cancer
Stage IV Sarcoma of Bone
Stage IV Lymphoma

Interventions: Drug: Psilocybin

First Posted Date: 2024-05-16

Last Posted Date: 2024-07-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 15

Registration Number: NCT06416085

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

ALTERNATE DAY ULTRAHYPOFRACTIONATED OR DAILY MODERATELY HYPOFRACTIONATED POST OPERATIVE RADIOTHERAPY (AMPORA)

Phase 2

Recruiting

Conditions: Post-Operative Prostate Cancer

Interventions: Radiation: Radiotherapy

First Posted Date: 2024-05-10

Last Posted Date: 2024-12-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 204

Registration Number: NCT06409910

Locations: 🇨🇦
University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN)

Phase 1

Recruiting

Conditions: Chemotherapy-induced Peripheral Neuropathy

Interventions: Behavioral: EX-CIPN

First Posted Date: 2024-05-08

Last Posted Date: 2024-05-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT06405542

Locations: 🇨🇦
ELLICSR: Health Wellness and Cancer Survivorship Centre, Toronto, Ontario, Canada

Albumin Utilization in Adult Cardiac Surgical Patients : A Multicentre Prospective Cohort Study

Recruiting

Conditions: Antithrombin III Levels
Albumin Levels

First Posted Date: 2024-05-02

Last Posted Date: 2024-10-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT06395480

Locations: 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦
Toronto General Hospital - University Health Network, Toronto, Ontario, Canada

EASE-SOT Pilot Study

Not Applicable

Not yet recruiting

Conditions: Transplant;Failure,Kidney
Transplant; Failure, Heart
Transplant; Failure, Pancreas
Transplant; Failure, Liver
Transplant; Failure, Lung(S)

Interventions: Other: EASE-SOT

First Posted Date: 2024-05-02

Last Posted Date: 2024-05-02

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 120

Registration Number: NCT06396702

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation

Phase 4

Not yet recruiting

Conditions: Distal Radius Fractures

Interventions: Drug: Topical TRanexamic Acid
Drug: Placebo

First Posted Date: 2024-04-25

Last Posted Date: 2024-04-26

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 90

Registration Number: NCT06384456

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Belimumab in Autoimmune Hepatitis

Phase 2

Recruiting

Conditions: Autoimmune Hepatitis

Interventions: Drug: Belimumab Auto-Injector [Benlysta]

First Posted Date: 2024-04-24

Last Posted Date: 2024-12-31

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 48

Registration Number: NCT06381453

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID-19 Cognitive Dysfunction

Phase 1

Completed

Conditions: Post COVID-19 Condition

Interventions: Device: Hi-OxSR Sequential Rebreathing mask (oxygen concentrator)

First Posted Date: 2024-04-23

Last Posted Date: 2024-04-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 37

Registration Number: NCT06379620

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy